It has been reported that L-Dopa decarboxylase (DDC) is an AR coactivator that increases in expression with disease progression, and is co-expressed with AR in prostate adenocarcinoma cells, where it may enhance AR activity. The gene discussed is AR; the disease is prostate adenocarcinoma.